The Atlantic Philanthropies is awarding UCSF and Trinity College Dublin, the University of Dublin, $177 million to create the Global Brain Health Institute, a groundbreaking venture to stem the precipitous rise in dementia by training and connecting a new generation of leaders worldwide.
The highest honor of the American College of Rheumatology has been awarded to David Wofsy, director of the Russell/Engleman Rheumatology Research Center at UCSF.
An international team of scientists led by UCSF researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer.
Although adults with serious psychiatric disorders are at high risk for diabetes, a large study led by UCSF reveals that low-income patients on Medicaid are rarely screened for it.
Scientists at the UNC School of Medicine (UNC) and UCSF have created a general tool to probe the activity of orphan receptors, illuminating their roles in behavior and making them accessible for drug discovery.
In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, UCSF researchers have identified strong evidence of efficacy for transgender women when PrEP is used consistently.
Annual Institute for Human Genetic's symposium dedicated to recognition of Y.W.Kan's achievements.
A chemical that could potentially be used in eye drops to reverse cataracts has been identified by a team of scientists from UCSF, the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
A gift of $20 million from the Ray and Dagmar Dolby Family Fund to the Department of Psychiatry at UCSF will support research on mood disorders.
Development of a surgically implantable, artificial kidney has received a $6 million boost, thanks to a new grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).